share_log

Here's How Much $100 Invested In Biogen 15 Years Ago Would Be Worth Today

Here's How Much $100 Invested In Biogen 15 Years Ago Would Be Worth Today

以下是15年前投资于生物遗传公司的100美元今天的价值
Benzinga Real-time News ·  2022/06/28 00:15

Biogen (NASDAQ:BIIB) has outperformed the market over the past 15 years by 3.63% on an annualized basis producing an average annual return of 10.11%. Currently, Biogen has a market capitalization of $31.20 billion.

生物遗传研究(纳斯达克:BIIB)过去15年的年化表现优于大市3.63%,平均年回报率为10.11%。目前,Biogen的市值为312.亿美元。

Buying $100 In BIIB: If an investor had bought $100 of BIIB stock 15 years ago, it would be worth $430.05 today based on a price of $213.03 for BIIB at the time of writing.

在BIIB购买100美元:如果一位投资者在15年前购买了100美元的BIIB股票,那么这笔钱就值了$430.05今天,以撰写本文时BIIB的213.03美元价格计算。

Biogen's Performance Over Last 15 Years

生物遗传研究公司过去15年的业绩

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

最后--这一切有什么意义?从这篇文章中获得的关键见解是注意到复合回报在一段时间内可以在你的现金增长中产生多大的差异。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动内容引擎生成,并由编辑审阅。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发